Announced Thu, 2 Jul · 18:23 IST
Aster DM board revamp post QCIL merger: 4 directors, IR head exit
ASTERDM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹790.05
prior close
₹791.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.1+0.1+0.3-0.1-0.0-1.1+2.3+2.3+3.2-0.2———
Up moveDown movePending
AI summary
Aster DM Healthcare is revamping its board after the Quality Care India merger. Four directors resigned effective July 1, 2026, including two independents and two non-executives. Chief IR and M&A Officer Hitesh Dhaddha also resigned effective July 18. New appointments include Varun Khanna as Managing Director, Blackstone nominees Ganesh Mani and Ayshwarya Vikram, three new independent directors, and multiple new CEOs across India and Bangladesh operations.
Likely market impact
Major board revamp post QCIL merger; fresh leadership from Blackstone and QCIL takes charge. Watch for governance continuity.